Sharps Compliance (SMED) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Sharps Compliance Reports Fiscal 2022 Second Quarter Results
January 26, 2022 6:55 AM ESTSecond quarter revenue of $18.9 million increased 11% from the prior year and 36% sequentiallyRoute-based customer locations increased 17% to 17,400 from 14,900 in the prior yearProfessional market billings grew 15% compared to prior year second quarterUnused medication revenue increased 9% driven by increased Inner Liner salesImmunization-related mailback billings increased by $2.8 million sequentially as compared to 1Q22, from $1.8 million to $4.6 million, reflecting COVID-19 vaccines and booster shots administered in the Retail Pharmacy marketClosed on Affordable Medical Waste acquisition on October 22, 2021Partnership with PharMerica recently announced to... More



